EUVIMEDEUVIMED entdecken
Übersichtsarbeit

30 years of nanobodies – an ongoing success story of small binders in biological research

Desiree I Frecot, Theresa Froehlich, Ulrich Rothbauer iD

Journal of Cell Science · 01.11.2023 · 136 (21)

DOI: 10.1242/jcs.261395 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cell Science, online erschienen am 08.11.2023. Verfasst von Desiree I Frecot und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Biotechnology, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tuebingen, Germany. Hauptthemen laut MEDLINE: Single-Domain Antibodies. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 165 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, State Ministry of Baden-Wuerttemberg for Economic Affairs, Labour and Tourism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A milestone in the field of recombinant binding molecules was achieved 30 years ago with the discovery of single-domain antibodies from which antigen-binding variable domains, better known as nanobodies (Nbs), can be derived. Being only one tenth the size of conventional antibodies, Nbs feature high affinity and specificity, while being highly stable and soluble. In addition, they display accessibility to cryptic sites, low off-target accumulation and deep tissue penetration. Efficient selection methods, such as (semi-)synthetic/naïve or immunized cDNA libraries and display technologies, have facilitated the isolation of Nbs against diverse targets, and their single-gene format enables easy functionalization and high-yield production. This Review highlights recent advances in Nb applications in various areas of biological research, including structural biology, proteomics and high-resolution and in vivo imaging. In addition, we provide insights into intracellular applications of Nbs, such as live-cell imaging, biosensors and targeted protein degradation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain Antibodies

Stichwörter der Autor:innen

Affinity captureCrystallizationIntracellular protein manipulationLive-cell imagingNanobodies

Substanzen

Single-Domain Antibodies

Autor:innen und Institutionen

  • Pharmaceutical Biotechnology, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tuebingen, Germany.
  • NMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstrasse 55, 72770 Reutlingen, Reutlingen, Germany.

ORCID-Profile: Ulrich Rothbauer

Förderung

  • Deutsche Forschungsgemeinschaft
  • State Ministry of Baden-Wuerttemberg for Economic Affairs, Labour and Tourism

Zitieren

APA

Frecot, D. I., Froehlich, T., & Rothbauer, U. (2023). 30 years of nanobodies – an ongoing success story of small binders in biological research. Journal of Cell Science, 136(21). https://doi.org/10.1242/jcs.261395

Vancouver

Frecot DI, Froehlich T, Rothbauer U. 30 years of nanobodies – an ongoing success story of small binders in biological research. Journal of Cell Science. 2023;136(21). doi:10.1242/jcs.261395

BibTeX
@article{Frecot2023,
  author = {Frecot, Desiree I and Froehlich, Theresa and Rothbauer, Ulrich},
  title = {30 years of nanobodies – an ongoing success story of small binders in biological research},
  journal = {Journal of Cell Science},
  year = {2023},
  volume = {136},
  number = {21},
  doi = {10.1242/jcs.261395}
}
Kostenlos starten →